- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Ochsner Names 2019 Alton Ochsner Award Relating Smoking and Disease Honorees
For 34 years, Ochsner Health System has annually recognized scientists who have made major contributions regarding the relationship between smoking and disease along with the development of innovative treatment modalities.
For 34 years, Ochsner Health System has annually recognized scientists who have made major contributions regarding the relationship between smoking and disease along with the development of innovative treatment modalities. The 2019 Alton Ochsner Award Relating Smoking and Disease Award has been bestowed to:
Paul M. Cinciripini, PhD (Professor, Department of Behavioral Science and Director, Tobacco Treatment Program at The University of Texas MD Anderson Cancer Center in Houston, Texas)
Edwin K. Silverman, MD, PhD (Professor of Medicine at Harvard Medical School and Physician, Department of Medicine, Pulmonary and Critical Care at Brigham and Women’s Hospital in Boston, Massachusetts)Each honoree will receive a $7500 honorarium, an award medallion, and a plaque describing key research findings.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
